نتائج البحث

BMI trajectories are associated with NAFLD and advanced fibrosis via aging-inflammation mediation.

• Authors : Peng H; Department of Hepatobiliary Surgery, Second Hospital Affiliated to Chongqing Medical University, Chongqing, P. R. China.; Zhao Z

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/epidemiology ; Body Mass Index* ; Inflammation*

• Source: BMC public health [BMC Public Health] 2025 Jan 14; Vol. 25 (1), pp. 147. Date of Electronic Publication: 2025 Jan 14.Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458

تفاصيل العنوان

Association between NAFLD and liver fibrosis with nutritional risk index based on the NHANES 2017-2018.

• Authors : Jian J; Department of Endocrinology, Translational Research of Diabetes Key Laboratory of Chongqing Education Commission of China, the Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.; Zhang R

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/epidemiology ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/pathology ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/pathology

• Source: Lipids in health and disease [Lipids Health Dis] 2025 Jan 07; Vol. 24 (1), pp. 6. Date of Electronic Publication: 2025 Jan 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101147696 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-511X

تفاصيل العنوان

The effect of probiotic supplementation on non-alcoholic fatty liver disease (NAFLD) fibrosis score in patients attending a tertiary hospital clinic in Cairo, Egypt.

• Authors : Abd El Hamid AA; Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.; Mohamed AE

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/therapy ; Probiotics*/Probiotics*/Probiotics*/therapeutic use ; Tertiary Care Centers*

• Source: BMC gastroenterology [BMC Gastroenterol] 2024 Oct 08; Vol. 24 (1), pp. 354. Date of Electronic Publication: 2024 Oct 08.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

تفاصيل العنوان

Association between the cardiometabolic index and NAFLD and fibrosis.

• Authors : Yan L; Department of Cardio Surgery Intensive Care Unit, Ningbo Medical Centre Li Huili Hospital, Ningbo, China.; Hu X

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/pathology ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/diagnostic imaging ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/pathology

• Source: Scientific reports [Sci Rep] 2024 Jun 08; Vol. 14 (1), pp. 13194. Date of Electronic Publication: 2024 Jun 08.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

FAST and Agile-the MASLD drift: Validation of Agile 3+, Agile 4 and FAST scores in 246 biopsy-proven NAFLD patients meeting MASLD criteria of prevalent caucasian origin.

• Authors : Taru MG; Faculty of Medicine, 'Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca, Cluj, Romania.; Regional Institute of Gastroenterology and Hepatology 'Octavian Fodor', Cluj-Napoca, Cluj, Romania.

Subjects: Elasticity Imaging Techniques*/Elasticity Imaging Techniques*/Elasticity Imaging Techniques*/methods ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/pathology ; Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/diagnosis

• Source: PloS one [PLoS One] 2024 May 23; Vol. 19 (5), pp. e0303971. Date of Electronic Publication: 2024 May 23 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD And/or Alcoholic Patients (SOPRANO)

• Source: Screening in Primary Care of Advanced Liver Fibrosis in NAFLD And/or Alcoholic Patients

تفاصيل العنوان

An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography

• Authors : Liang, Jia-xu; Ampuero, Javier; Niu, Hao

Subjects: Biomedical and Clinical Sciences; Clinical Sciences; Obesity

• Source: Journal of Hepatology. 79(3)

تفاصيل العنوان

Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients At Assiut University Hospital (NAFLD and SLE)

• Authors : Ayman Makram Ayad Souliman, physician

• Source: Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients At Assiut University HospitalYetginoglu O, Atas DB, Yilmaz Y, Velioglu A, Arikan H,

تفاصيل العنوان

Neck circumference as a screening measure for identifying NAFLD among a group of academic employees in Bangkok, Thailand.

• Authors : Suwimol S; Medical Food Research Group, Nutrition and Dietetics Department, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand.; Pisit T

Subjects: Body Mass Index* ; Waist Circumference*; Liver Cirrhosis/Liver Cirrhosis/Liver Cirrhosis/*diagnosis

• Source: PloS one [PLoS One] 2022 Feb 17; Vol. 17 (2), pp. e0263826. Date of Electronic Publication: 2022 Feb 17 (Print Publication: 2022).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease.

• Authors : Unsal İO; Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Sehit Omer Halisdemir Avenue, 06110, Ankara, Turkey. .; Calapkulu M

Subjects: Decision Support Techniques*; Blood Glucose/Blood Glucose/Blood Glucose/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

• Source: Scientific reports [Sci Rep] 2022 Jan 07; Vol. 12 (1), pp. 283. Date of Electronic Publication: 2022 Jan 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان